Cancer Education and Research Institute (CERI)'s Cancer Education Programs 

Our Team of cancer experts at Cancer Education and Research Institute® (CERI)'s, formerly Cancer Research Simplified, provides you with the most reliable, most up-to-date, and simplified cancer information available. Our educational programs quickly became trusted and highly sought after worldwide.  

CERI strongly stands behind the importance of cancer patient empowerment and is a worldwide leading source for simplified, multi-language cancer education.  Knowledge is power and empowerment is the key for greater treatment success, early diagnosis, as well as cancer prevention.  

For any questions or requests, please submit your inquiry at our CERI Personalized Patient Program™ page.

Cholangiocarcinoma (Bile Duct Cancer)

Aygün Sahin, MSc, PhD  | CEO, President, and Cancer Lead, Cancer Education and Research Institute (CERI)

What is Cholangiocarcinoma (CCA)?

Suggestion: Watch this video on Liver Cancer

Here we describe what Cholangiocarcinoma (CCA) is, who could get CCA (bile duct cancer), its risk factors, causes, symptoms, diagnosis, and treatment in a detailed, yet simplified way.
Liver cancer - all you need to know

What are the facts for Cholangiocarcinoma?

What are the Cholangiocarcinoma types?

What are the risk factors for Cholangiocarcinoma?

Intrahepatic Cholangiocarcinoma Risk Factors

What are the types of Cholangiocarcinoma?

Watch our video on carcinoma types to learn more about adenocarcinoma:

What are the symptoms of Cholangiocarcinoma?

Coming soon - check back in!

How is Cholangiocarcinoma diagnosed?

How is Cholangiocarcinoma treated?

Coming soon - check back in!

What can you do to prevent Cholangiocarcinoma?

Coming soon - check back in!

Breaking News:

Bile duct cancer patients can live longer study finds.

New Research: Immunotherapy - Personalized Medicine

Terminal Bile Duct Cancer completely eradicated in an UK immunotherapy + chemotherapy combo trial - Importance of PERSONALIZED MEDICINE

To learn more about the details of this study and everything you need to know about clinical trials, click here. 
References:
  1. Cholangiocarcinoma. Krasinskas, AM. Surg Pathol Clin. 2018 Jun; 11(2):403-429.
  2. Cholangiocarcinoma. Razumilava, N. and Gores, GJ. Lancet. 2014 Jun 21; 383(9935):2168-79.
  3. https://www.mayoclinic.org/diseases-conditions/cholangiocarcinoma/symptoms-causes/syc-20352408 (accessed July 30, 2021)
  4. https://medlineplus.gov/genetics/condition/cholangiocarcinoma (accessed July 30, 2021)

#Empowermentagainstcancer™ #CERICares  #CERIinforms  #CancerSimplified  
#Cholangiocarcinoma #bileductcancer #cancer #Cholangiocarcinomasymptoms #bileductcancersymptoms #Cholangiocarcinomadiagnosis #bileductcancerdiagnosis #Cholangiocarcinomafacts #bileductcancerfacts #Cholangiocarcinomarisks #bileductcancerrisks #Cholangiocarcinomadiagnosis #bileductcancerdiagnosis #Cholangiocarcinomatreatment #bileductcancertreatment #Cholangiocarcinomasurvivors #bileductcancersurvivors #cancereducation #cancerresearch #adenocarcinoma #cancertreatment
GET YOUR FREE ARTICLE: Make sure to get your free article as our gift to you! Go to: canceredinstitute.org/ceri-simplified-cancer-research-articles

CORONAVIRUS PAGE: For our educational and up-to-date informational page on Coronavirus, go to: canceredinstitute.org/coronavirus

FOLLOW US for DAILY information and updates: 

You might also like:


Disclaimer: We can not assume responsibility of misinterpretation of content.

    Help us to serve you better!